Ambu A/S (AMBFF)

Market Cap	4.74B
Revenue (ttm)	783.93M
Net Income (ttm)	45.26M
Shares Out	n/a
EPS (ttm)	0.17
PE Ratio	104.65
Forward PE	n/a
Dividend	0.05 (0.28%)
Ex-Dividend Date	Dec 5, 2024

Volume	150
Average Volume	2,831
Open	19.35
Previous Close	19.50
Day's Range	19.35 - 19.35
52-Week Range	17.25 - 20.50
Beta	0.79
RSI	58.24
Earnings Date	May 7, 2025

About Ambu A/S

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1937
• Employees: 5,196
• Stock Exchange: OTCMKTS
• Ticker Symbol: AMBFF

Financial Performance

In 2024, Ambu A/S's revenue was 5.39 billion, an increase of 12.90% compared to the previous year's 4.78 billion. Earnings were 235.00 million, an increase of 39.88%.

Financial numbers in DKK